阿仑单抗选择性靶向T和B细胞群治疗多发性硬化症

{"title":"阿仑单抗选择性靶向T和B细胞群治疗多发性硬化症","authors":"N. Grigoriadis","doi":"10.17925/ENR.2017.12.02.78","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":12047,"journal":{"name":"European neurological review","volume":"12 1","pages":"78"},"PeriodicalIF":0.0000,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Selective Targeting of T and B Cell Populations by Alemtuzumab in the Treatment of Multiple Sclerosis\",\"authors\":\"N. Grigoriadis\",\"doi\":\"10.17925/ENR.2017.12.02.78\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":12047,\"journal\":{\"name\":\"European neurological review\",\"volume\":\"12 1\",\"pages\":\"78\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European neurological review\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17925/ENR.2017.12.02.78\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European neurological review","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17925/ENR.2017.12.02.78","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}